Pharma and BioTech Daily

Beam Therapeutics' base editing therapy risto-cel meets its primary endpoint in the pivotal BEACON sickle cell study, and the FDA approves Pimjetmi, pimicotinib, from Abbisko and Merck KGaA for tenosynovial giant cell tumor. Also: BIO's BioAdvance plan to keep the US ahead of China in biotech, Gossamer Bio prepares a seralutinib launch after its first NDA, and the FDA clears Metagenomi&a...

Vir Biotechnology reports a pivotal Phase 3 win in chronic hepatitis delta, and argenx agrees to buy Unnatural Products for up to 1.15 billion dollars to add oral macrocyclic peptides. Also: TG Therapeutics raises Briumvi guidance, Xenon's azetukalner filing and X-NOVA2 timing, and Atea's path to a hepatitis C filing. Good morning from Pharma and Biotech Daily, the briefing on what matte...

Full Lp(a)HORIZON results at AHA show Novartis' pelacarsen cut Lp(a) by 78 percent with no cardiovascular benefit, as the FDA heads into a crowded month of decisions on ivonescimab, deramiocel and povetacicept. Also: Mineralys' lorundrostat holds its effect at 48 weeks, Sarepta's new CEO faces falling Elevidys sales, and Moderna raises guidance. Good morning from Pharma and Biotech...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of exciting advancements and strategic shifts reshaping the landscape of drug development and patient care. A noteworthy collaboration between Zealand Pharma and Generate:Biomedicines is leading the charge, aiming to revolutionize treatm...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into some of the most compelling stories shaping the industry. Let's begin with GSK's bold move to expand its biologics capabilities. The company has announced an $800 million investment in a new biologics production facility and in...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of compelling stories that highlight the dynamic nature of the industry, marked by strategic acquisitions, groundbreaking research, and significant regulatory milestones. Starting with Asahi Kasei's acquisition of Bayer spinout AiCu...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of significant advancements and strategic shifts shaping the industry landscape. We begin with the integration of artificial intelligence into drug discovery. GSK's recent collaboration with Chai Discovery exemplifies the g...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant advancements and challenges shaping these dynamic sectors. In a notable regulatory update, the U.S. Food and Drug Administration has expanded the label for Novartis' Rhapsido to include symptomatic dermographism,...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of impactful advancements and strategic shifts shaping the industry landscape. Cerevance has made headlines with its drug Solengepras achieving a major milestone in a Phase 3 trial for Parkinson's disease. The drug signific...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The pharmaceutical industry is no stranger to dynamic growth, as evidenced by Shionogi's recent acquisition of Intrabio for a staggering $2 billion. This move is more than just a financial transaction; it represents a strategic pivot towards addressing rare dise...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of groundbreaking advancements and strategic shifts that are defining the industry's path forward. Bayer has made headlines with its strategic $2.2 billion investment in a new Ohio manufacturing site. This move highlights t...

Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the rapidly evolving landscape of drug development, where groundbreaking scientific advances and strategic corporate maneuvers are reshaping patient care and industry standards. The integration of artificial intelligence in drug discovery is gain...

Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape is constantly evolving, with innovative partnerships, groundbreaking clinical trial results, and regulatory shifts shaping the future of healthcare. Today, we delve into these key areas, highlighting significant industry movements and their potential im...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the latest breakthroughs and trends shaping the landscape of medicine and treatment. In the realm of weight management and metabolic disorders, significant advancements are underway. Roche and Zealand Pharma have moved Petrelintide, an amylin ana...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of transformative developments across the pharmaceutical and biotech sectors, highlighting strategic investments, innovative therapies, and regulatory milestones. AstraZeneca's recent $2 billion investment in Summit Therapeutics is...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Recent updates in these sectors have highlighted significant scientific advancements, regulatory milestones, and promising clinical trial results that could impact patient care and drug development. One of the standout developments is the FDA's approval of AbbVi...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The landscape of these industries is currently experiencing a wave of transformative changes, from strategic corporate relocations and groundbreaking partnerships to pivotal regulatory approvals and promising clinical trial outcomes. Let's begin with a significa...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of recent breakthroughs and strategic moves that are shaping the future of drug development and patient care. Eli Lilly has achieved a significant milestone with the FDA's approval of Onswik, a once-weekly insulin therapy f...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of scientific advances and strategic collaborations shaping patient care and drug development globally. AstraZeneca recently achieved a significant milestone with the European Union's approval of Trixeo, a combination t...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The industry is pulsating with advancements, strategic collaborations, regulatory approvals, and promising clinical trial results that are reshaping the landscape of healthcare and drug development. A notable collaboration making waves is between Boehringer Ingelheim...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a period of profound transformation within the industry, marked by scientific advancements, strategic acquisitions, and a shifting regulatory landscape that promises to redefine the future of healthcare. Telix Pharmaceuticals has made headlines w...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of groundbreaking advancements and strategic shifts shaping the future of this dynamic industry. The FDA has recently approved Ultragenyx's gene therapy, Fayuvi, for a rare neurodegenerative disorder, marking a significant milestone...

Good morning from Pharma Daily, the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of pivotal advancements and strategic maneuvers shaping the landscape of drug development and patient care. Bayer's Kerendia, known generically as finerenone, has achieved its third FDA approval, this time targeting chronic...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of dynamic and significant advancements across the industry, from strategic acquisitions to regulatory shifts and scientific innovations. In a bold move, Novartis has acquired Sironax's blood-brain barrier delivery platform...

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant strides and strategic maneuvers reshaping the landscape of healthcare and drug development. Kicking things off, GlaxoSmithKline (GSK) has made headlines with its acquisition of Chimagen Biosciences' trispecific T cell...